feed,title,long_url,short_url
Barron's,BridgeBio Stock Plunges After Acoramidis Phase 3 Trial Fails to Meet Endpoint,https://www.barrons.com/articles/bridgebio-pharma-stock-price-acoramidis-trial-51640610741?mod=RTA,https://j.mp/3z5RG8e
